Aucun résultat
Christoph Borchers is recognized as a pioneer and leading figure in the development of mass spectrometry-based methods for protein quantification using Multiple Reaction Monitoring (MRM) and structural proteomics. He has published more than 350 peer-reviewed papers which have been cited more than 29,000 times (h-factor 82). He is the founder and director of the McGill-Lady Davis Institute for Medical Research Integrated Proteomics Program at the Jewish General Hospital, McGill University, where he is currently a Full Professor in the Gerald Bronfman Department of Oncology.
Christoph Borchers received his PhD degree from the University of Konstanz, Germany in 1996. After his post-doctoral training at the NIEHS/NIH/RTP, NC he became the director of the UNC-Duke Proteomics Facility and held a faculty position at the UNC Medical School in Chapel Hill, NC (2001-2006). From 2006 to 2019, he was a Professor in the Department of Biochemistry & Microbiology, and Director of the University of Victoria-Genome BC Proteomics Centre at the University of Victoria, BC, Canada, where he held the Rix BC Leadership Chair in Biomedical and Environmental Proteomics.
Christoph Borchers was also involved in promoting proteomics research and education through his involvement with HUPO (International Council Member), the British Columbia Proteomics Network (Executive Committee Member, past Scientific Director) and the Canadian National Proteomics Network (Member, past VP External, President and Chair of the Board of Directors). He is also a Fellow of the Canadian Academy of Health Sciences.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
